Skip to main content
Premium Trial:

Request an Annual Quote

Viaken, Clarkston Team Up to Offer On-Line Informatics Solutions

NEW YORK, Oct 31 – Viaken Systems and Clarkston, an e-business consulting firm, have teamed up to develop platforms that will allow life science companies to build research infrastructures at lower costs, Viaken said Tuesday.

Monty Hamilton, vice president of business development at Clarkston, of Durham, NC, said the alliance would combine Clarkston’s front and back office solutions with Viaken’s drug discovery abilities. The companies’ potential customers will include pharmaceutical and biotech companies in the early stages of the drug development process.

“Now, we have the opportunity to leverage our project management and solutions expertise with Viaken’s drug discovery expertise to help our pharmaceutical and biotech clients in the early stages of the drug development process,” Hamilton said in a statement. “This alliance will enable our clients to discover promising drug compounds faster, and get them to the market sooner and at less cost."

Viaken of Gaithersburg said that through the alliance the companies would ease the IT burdens drug discovery companies face.

" Our clients are looking for one-stop shopping and a single point of accountability for their IT solutions, whether the solution is for drug discovery or enterprise resource planning," Keith Elliston, president and CEO of Viaken said.

Financial terms of the deal were not disclosed.

Viaken offers informatics services to the life science industry and markets a customized hosting platform known as Viaken Informatics Environment.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.